Which antifungal drugs are safe to use during pregnancy?

Safe Antifungal Drugs During Pregnancy

Amphotericin B is the safest systemic antifungal for pregnancy and should be used for serious fungal infections, particularly during the first trimester 1.

First-Line Agents by Trimester and Route

First Trimester (Critical Period)

Systemic infections:

• Amphotericin B (intravenous) is the drug of choice for all serious fungal infections during the first trimester 1, 2, 3
• Azole antifungals (fluconazole, itraconazole) carry teratogenic risk at high doses (≥400 mg daily) and should be avoided 1, 2

Topical/superficial infections:

• Clotrimazole - first-line for vulvovaginal candidiasis 4, 5
• Miconazole - safe alternative 4, 5
• Nystatin - safe for mucocutaneous infections 5

Second and Third Trimesters

After the first trimester, azole antifungals can be cautiously used since teratogenic effects occur primarily during early embryogenesis 1. However, amphotericin B remains the safer choice when feasible 1.

Specific Drug Safety Profile

SAFE Throughout Pregnancy:

• Amphotericin B (IV/intrathecal) - extensive clinical experience, preferred for systemic infections 1, 2, 3
• Topical clotrimazole - established safety, reference standard 4, 5
• Topical miconazole - no increased malformation risk 4, 5
• Nystatin - limited absorption, safe 5

USE WITH CAUTION (Second-line):

• Topical oxiconazole - no increased risk in recent data 4
• Topical isoconazole - appears safe 4
• Topical butenafine, ciclopirox, naftifine, terbinafine - may use after first-line agents 5

AVOID or Use Only After First Trimester:

• High-dose fluconazole (≥400 mg daily) in first trimester - associated with Antley-Bixler-like syndrome (craniosynostosis, skeletal abnormalities, cleft palate) 1, 2
• Single low-dose fluconazole for vaginal candidiasis appears safer but still warrants caution 2
• Oral itraconazole - possible increased risk of eye defects 6
• Topical econazole - avoid first trimester, use sparingly thereafter 5

CONTRAINDICATED:

• Griseofulvin - serious teratogenic risk 3
• Ketoconazole (systemic) - teratogenic 3
• Voriconazole - teratogenic 3
• Flucytosine - teratogenic 3
• Potassium iodide - fetal malformations 3

Clinical Decision Algorithm

For systemic/serious fungal infections:

1. Use amphotericin B regardless of trimester
2. If patient already on azole therapy when pregnancy discovered:
   • First trimester: Switch to amphotericin B OR continue azole with informed consent about risks 1
   • After first trimester: May continue azole or switch to amphotericin B based on clinical judgment 1

For superficial infections (vulvovaginal candidiasis):

1. Use topical clotrimazole as first choice 4, 5
2. Alternative: topical miconazole or nystatin 4, 5
3. Avoid oral azoles unless absolutely necessary

For meningeal infections:

• Intrathecal amphotericin B is the safest option, though challenging 1
• Oral azoles may be continued with patient education about fetal risks if intrathecal therapy not feasible 1

Critical Caveats

Dose matters: The teratogenic risk of fluconazole is dose-dependent. High doses (≥400 mg daily) during first trimester are associated with specific congenital malformations including craniosynostosis, skeletal abnormalities, and cleft palate 1, 2. Single low-dose therapy appears safer but recent data suggest even topical azoles may affect fetal steroidogenesis 7.

Timing is critical: Teratogenic effects occur during first trimester organogenesis. After 12-14 weeks, azoles are considerably safer 1.

Breastfeeding: Fluconazole appears safe during breastfeeding, but other azoles should be avoided 1.

Emerging concerns: Recent 2026 data suggest even topical azoles (clotrimazole, miconazole) may disrupt fetal steroidogenesis and affect reproductive development 7, though this requires further validation before changing current practice recommendations.